Back to search

Poland· PL-100488184

Noradrenaline Swiss2Care

A norepinephrine product containing noradrenalinum, registered in Poland by Swiss2Care Sp. z o.o. Sp. k.. The same ATC class is registered in 13 of our 19 countries.

ATC C01CA03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNoradrenaline Swiss2CareATCC01CA03REGISTER NO.PL-100488184PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Norepinephrine is registered in 13 of 19 countries.

Countries holding a registration under ATC C01CA03 (norepinephrine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Norepinephrine · ATC C01CA03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Noradrenalinum
Manufacturer
Swiss2Care Sp. z o.o. Sp. k.
Country
Poland (PL)
ATC code
C01CA03
ATC class
Norepinephrine
Defined daily dose
6 mg, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991523114
  • gtin
    05909991523107

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

89 interactions on record for norepinephrine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Norepinephrine · interactions on record

89 records

  • 3 severe
  • 86 moderate

Most severe, free to view

  • CocaineN01BC01severe
  • DoxepinN06AA12severe
  • CocaineR02AD03severe
  • PhentermineA08AA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e418771a-e520-41ab-834a-4ca8870c30a4
GET /v1/drugs/e418771a-e520-41ab-834a-4ca8870c30a4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Koncentrat do sporządzania roztworu do infuzji",
  "source": "urpl",
  "strength": "1 mg/ml",
  "packaging": "05909991523107 ¦ Lz ¦ 151580\n10 ampułek 4 ml\n05909991523114 ¦ Lz ¦ 151581\n10 ampułek 8 ml",
  "substance": "Noradrenalinum 1 mg/ml",
  "common_name": "Noradrenalinum",
  "pl_product_id": "100488184",
  "pozwolenie_nr": "217/23",
  "auth_procedure": "IR",
  "authorisation_validity": "2028-10-03"
}

See everything about norepinephrine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.